KRAS mutation detection in colorectal cancer by a commercially available gene chip array compares well with Sanger sequencing

This study indicates the utility of the AutoGenomics INFINITI® methodology in a clinical laboratory setting where technical expertise or access to equipment for DNA sequencing does not exist.